For the years ended March 31,

2026

2025

2024

Numerator:

Net loss from continuing operation attributable to Akso Health Group’s shareholder

$

(18,671,610

)

$

(134,977,369

)

$

(9,058,986

)

Net loss from discontinued operation attributable to Akso Health Group’s shareholders

—

——

(399,798

)

Net loss attributable to Akso Health Group’s shareholders

$

(18,671,610

)

$

(134,977,369

)

$

(9,458,784

)

Denominator:

Weighted average number of ordinary shares outstanding—basic

2,168,121,761

855,288,335

141,516,777

Weighted average number of dilutive potential ordinary shares from share options

—

Weighted average number of ordinary shares outstanding—diluted

2,168,121,761

855,288,335

141,516,777

Basic (loss) per common share

$

(0.01

)

$

(0.16

)

$

(0.07

)

Diluted (loss) per common share

$

(0.01

)

$

(0.16

)

$

(0.07

)